Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RG 6287

Next Previous
Search
Drug Profile

RG 6287

Alternative Names: GDC-8264; RG-6287; RO 7288817

Latest Information Update: 28 Mar 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Genentech
  • Class Anti-inflammatories
  • Mechanism of Action Receptor-interacting protein serine-threonine kinase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase II Acute kidney injury
  • Phase I Graft-versus-host disease
  • No development reported Inflammation; Inflammatory bowel diseases

Most Recent Events

  • 28 Mar 2025 No recent reports of development identified for phase-I development in Graft-versus-host-disease in USA (PO, Tablet)
  • 28 Mar 2025 No recent reports of development identified for phase-I development in Inflammatory-bowel-diseases(In volunteers) in Netherlands (PO, Tablet)
  • 28 Jan 2025 No recent reports of development identified for phase-I development in Inflammation(In volunteers) in USA (PO, Tablet)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top